These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36163209)

  • 21. Chronic liver involvement in urea cycle disorders.
    Ranucci G; Rigoldi M; Cotugno G; Bernabei SM; Liguori A; Gasperini S; Goffredo BM; Martinelli D; Monti L; Francalanci P; Candusso M; Parini R; Dionisi-Vici C
    J Inherit Metab Dis; 2019 Nov; 42(6):1118-1127. PubMed ID: 31260111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological implications of urea cycle disorders.
    Gropman AL; Summar M; Leonard JV
    J Inherit Metab Dis; 2007 Nov; 30(6):865-79. PubMed ID: 18038189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene correction in patient-specific iPSCs for therapy development and disease modeling.
    Jang YY; Ye Z
    Hum Genet; 2016 Sep; 135(9):1041-58. PubMed ID: 27256364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in diagnosing and managing adult patients with urea cycle disorders.
    Stepien KM; Geberhiwot T; Hendriksz CJ; Treacy EP
    J Inherit Metab Dis; 2019 Nov; 42(6):1136-1146. PubMed ID: 30932189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urea cycle disorders-update.
    Matsumoto S; Häberle J; Kido J; Mitsubuchi H; Endo F; Nakamura K
    J Hum Genet; 2019 Sep; 64(9):833-847. PubMed ID: 31110235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for the treatment of urea cycle disorders.
    Whitington PF; Alonso EM; Boyle JT; Molleston JP; Rosenthal P; Emond JC; Millis JM
    J Inherit Metab Dis; 1998; 21 Suppl 1():112-8. PubMed ID: 9686349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.
    Kido J; Matsumoto S; Mitsubuchi H; Endo F; Nakamura K
    Metab Brain Dis; 2018 Oct; 33(5):1517-1523. PubMed ID: 29948653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
    Omole AE; Fakoya AOJ
    PeerJ; 2018; 6():e4370. PubMed ID: 29770269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.
    Agrawal A; Narayan G; Gogoi R; Thummer RP
    Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary urea cycle diseases in Finland.
    Keskinen P; Siitonen A; Salo M
    Acta Paediatr; 2008 Oct; 97(10):1412-9. PubMed ID: 18616627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012.
    Perito ER; Rhee S; Roberts JP; Rosenthal P
    Liver Transpl; 2014 Jan; 20(1):89-99. PubMed ID: 24136671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argininosuccinate lyase deficiency.
    Nagamani SC; Erez A; Lee B
    Genet Med; 2012 May; 14(5):501-7. PubMed ID: 22241104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics.
    Sen T; Thummer RP
    Neurotox Res; 2022 Oct; 40(5):1597-1623. PubMed ID: 36044181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.
    Häberle J; Burlina A; Chakrapani A; Dixon M; Karall D; Lindner M; Mandel H; Martinelli D; Pintos-Morell G; Santer R; Skouma A; Servais A; Tal G; Rubio V; Huemer M; Dionisi-Vici C
    J Inherit Metab Dis; 2019 Nov; 42(6):1192-1230. PubMed ID: 30982989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.
    Morioka D; Kasahara M; Takada Y; Shirouzu Y; Taira K; Sakamoto S; Uryuhara K; Egawa H; Shimada H; Tanaka K
    Liver Transpl; 2005 Nov; 11(11):1332-42. PubMed ID: 16237708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening.
    Aboul-Soud MAM; Alzahrani AJ; Mahmoud A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
    Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
    Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolving field of induced pluripotency: recent progress and future challenges.
    Sommer CA; Mostoslavsky G
    J Cell Physiol; 2013 Feb; 228(2):267-75. PubMed ID: 22767332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency.
    McGuire PJ; Tarasenko TN; Wang T; Levy E; Zerfas PM; Moran T; Lee HS; Bequette BJ; Diaz GA
    Dis Model Mech; 2014 Feb; 7(2):205-13. PubMed ID: 24271778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.